New ACD European subsidiary aims to provide faster, enhanced support for local customers

Easy ordering, fast delivery and enhanced support for EU customers

Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, has announced the establishment of a European subsidiary which will start business in October 2014.

The move comes shortly after the company announced its probe library had grown to over 4000 probes and is indicative of the growing international demand for RNAscope® assays. The assays represent a major technological advance for in situ RNA detection, enabling robust single RNA molecule detection for the first time in formalin-fixed, paraffin-embedded (FFPE) tissue. Since their commercialisation three years ago, these assays have been adopted across the globe by major pharma biotech companies and leading research institutions for drug discovery, translational research, and the development of clinical and companion diagnostic tests.

The news also highlights ACD’s continued commitment to providing exceptional customer service to its global customers; “ACD is very excited about the rapid expansion of our customer base in Europe," said ACD's Chief Operating Officer Steve Chen. "Establishing a local subsidiary is a natural next step for us to extend our market presence and provide a faster and enhanced level of service to our customers here.”

The ACD European subsidiary has a warehousing and distribution centre located close to Milan, Italy, and sales, marketing and technical support staff in Germany and the UK. Such an arrangement offers significant benefits to European customers and eliminates troublesome and unpredictable import/export border issues. Product delivery becomes faster and more reliable with urgent orders of in-stock items able to be shipped next-day within Europe. In addition, customers will be able to place orders in Euros and technical and logistic support will be provided locally within the same time zone.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Advanced Cell Diagnostics. (2019, June 18). New ACD European subsidiary aims to provide faster, enhanced support for local customers. News-Medical. Retrieved on October 07, 2024 from https://www.news-medical.net/news/20140916/New-ACD-European-subsidiary-aims-to-provide-faster-enhanced-support-for-local-customers.aspx.

  • MLA

    Advanced Cell Diagnostics. "New ACD European subsidiary aims to provide faster, enhanced support for local customers". News-Medical. 07 October 2024. <https://www.news-medical.net/news/20140916/New-ACD-European-subsidiary-aims-to-provide-faster-enhanced-support-for-local-customers.aspx>.

  • Chicago

    Advanced Cell Diagnostics. "New ACD European subsidiary aims to provide faster, enhanced support for local customers". News-Medical. https://www.news-medical.net/news/20140916/New-ACD-European-subsidiary-aims-to-provide-faster-enhanced-support-for-local-customers.aspx. (accessed October 07, 2024).

  • Harvard

    Advanced Cell Diagnostics. 2019. New ACD European subsidiary aims to provide faster, enhanced support for local customers. News-Medical, viewed 07 October 2024, https://www.news-medical.net/news/20140916/New-ACD-European-subsidiary-aims-to-provide-faster-enhanced-support-for-local-customers.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
300 research publications using ACD’s RNAscope® Technology